Thermo Fisher Scientific (TMO)

CrispIdea Report
Published: November 29, 2017

Web Price :


  • Sources: CrispIdea
  • Format: PDF
  • Language: English

TMO reported another great quarter results with both top-line and bottom-line numbers achieving double-digit growth. TMO came up with number of developments in this quarter. TMO also completed the acquisition of Patheon on 29th Aug, 2017.

The revenues for the quarter was $5.11bn as compared with $4.5bn for Q3FY16, which increased by 14% Y/Y. Sales
increased $378mn due to acquisition. The favorable effects of currency translation resulted in an increase in revenues of $44mn in 2017.

• Executive Summary
• Financial Statements
– Income Statement and Forecast
– Balance Sheet
– Cash Flow
– Q3FY17 Results – Overview
– Q3FY17 – Segment Performance
– Q3FY17 Results – New launches and Expansion
– Full Year FY17 Guidance and Conclusion
• Historical Performance
– Key Ratios
– Profitability Ratios, Asset Turnover Ratio, Growth Ratio
– Per Share Items and Key Ratios
– Key Balance Sheet and Cash Flow Items
• Product Performance and Key Developments
– Ownership
– Competitors
– Key Developments
• Valuation and Consensus Performance
– Relative Valuation
– Analyst Recommendations
• Market Price Performance